2011 - Intravenous infusions of TriN 2755, a new alkylating agent, inhibit the growth of human MDA-MB-231 breast tumour in Nude rats

M. Hillairet de Boisferona, Z. Kooba, F. Bichata, G. Ludwigb and W. Barthb 

aOncodesign, bTriN Therapeutics


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.